Individualizing Therapy in Low-Risk MDS: New Evidence and Options for Your Patients

Gain expert insights on the latest advancements in managing low-risk myelodysplastic syndromes through an on-demand webcast of a roundtable discussion and a commentary addressing audience questions from a live webinar.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb